Your browser doesn't support javascript.
loading
Pericytes/vessel-associated mural cells (VAMCs) are the major source of key epithelial-mesenchymal transition (EMT) factors SLUG and TWIST in human glioma.
Mäder, Lisa; Blank, Anna E; Capper, David; Jansong, Janina; Baumgarten, Peter; Wirsik, Naita M; Zachskorn, Cornelia; Ehlers, Jakob; Seifert, Michael; Klink, Barbara; Liebner, Stefan; Niclou, Simone; Naumann, Ulrike; Harter, Patrick N; Mittelbronn, Michel.
Afiliação
  • Mäder L; Edinger Institute (Neurological Institute), Goethe University, Frankfurt, Germany.
  • Blank AE; Edinger Institute (Neurological Institute), Goethe University, Frankfurt, Germany.
  • Capper D; Department of Neuropathology, University of Heidelberg, Heidelberg, Germany.
  • Jansong J; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Baumgarten P; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Neuropathology, Berlin, Germany.
  • Wirsik NM; Laboratory of Molecular Neuro-Oncology, Department of Vascular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
  • Zachskorn C; Edinger Institute (Neurological Institute), Goethe University, Frankfurt, Germany.
  • Ehlers J; Edinger Institute (Neurological Institute), Goethe University, Frankfurt, Germany.
  • Seifert M; Edinger Institute (Neurological Institute), Goethe University, Frankfurt, Germany.
  • Klink B; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Liebner S; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Niclou S; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Neuropathology, Berlin, Germany.
  • Naumann U; Department of Radiation Oncology, University of Tübingen, Tübingen, Germany.
  • Harter PN; Carl Gustav Carus Faculty of Medicine, Technische Universität Dresden, Institute for Medical Informatics and Biometry (IMB), Dresden, Germany.
  • Mittelbronn M; National Center for Tumor Diseases (NCT), Dresden, Germany.
Oncotarget ; 9(35): 24041-24053, 2018 May 08.
Article em En | MEDLINE | ID: mdl-29844871

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article